Frequently asked questions
The Sentimag® platform is the heart of our localisation technology. Using magnetic sensing it detects the Magseed® marker and Magtrace® lymphatic tracer, enabling physicians to carry out tumour localisations and breast cancer staging within one platform.
It produces an alternating magnetic field that temporarily magnetises any Magseed® marker or Magtrace® lymphatic tracer near the probe tip. The probe simultaneously detects tiny changes in the magnetic field around the probe, and these are converted into an audible response and numerical display that indicates the distances from the marker to the probe.
No. While the metallic instruments can affect the signal reading on the Sentimag®, this is only when they are in close proximity to the probe. For most cases you can simply remove them from the incision whilst sensing.
The price of a Sentimag® platform differs from country to country. Get in touch with our team of experts for more information.
Outside of the cost of the platform itself, there are several studies which have shown that the greater efficiencies from using the Sentimag® system can also result in significant cost savings for hospitals. This should also be considered alongside the price of the seed.